These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 375822)

  • 1. [Experimental characteristics of the antileishmaniasis action of amphotericin B].
    Liubimov LK; Fateeva LI; Sergeeva LA
    Antibiotiki; 1979 Apr; 24(4):281-4. PubMed ID: 375822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileishmanial activity of nano-amphotericin B deoxycholate.
    Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lipid preparations isolated from protozoa on experimental leishmaniasis in golden hamsters].
    Saf'ianova VM; Emel'ianova LP; Sukhareva NN; Uriniuk VM
    Antibiotiki; 1978 Nov; 23(11):1918-24. PubMed ID: 363050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative electron microscopic study of the ultrastructural changes in L. braziliensis promastigotes exposed to monomycin and amphoglucamine].
    Delektorskiĭ VV; Tishchenko LD; Alita OV; Saf'ianova VM; Emel'ianova LP
    Med Parazitol (Mosk); 1982; 60(2):62-5. PubMed ID: 6806591
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
    Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
    J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leishmanial activity of a new formulation of amphotericin B.
    Dea-Ayuela MA; Rama-Iñiguez S; Sánchez-Brunete JA; Torrado JJ; Alunda JM; Bolás-Fernández F
    Trop Med Int Health; 2004 Sep; 9(9):981-90. PubMed ID: 15361111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
    Sundar S; Mehta H; Chhabra A; Singh V; Chauhan V; Desjeux P; Rai M
    Clin Infect Dis; 2006 Mar; 42(5):608-13. PubMed ID: 16447104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the chemotherapeutic effect of paromomycin and monomycin in experimental cutaneous leischmaniasis in albino mice].
    Moskalenko NIu; Pershin GN
    Farmakol Toksikol; 1966; 29(1):90-4. PubMed ID: 4864948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of the effectiveness of antibacterial preparations in treating dysentery].
    Suptel' EA; Zagornaia NB; Bass TM
    Antibiotiki; 1979 Mar; 24(3):207-10. PubMed ID: 156002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensification of the cytostatic action of adriamycin and carminomycin by amphotericin B].
    Makukho LV; Volkolupova OP; Gauze GF
    Antibiotiki; 1980 Apr; 25(4):294-6. PubMed ID: 7369735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
    Sundar S; Chakravarty J; Rai VK; Agrawal N; Singh SP; Chauhan V; Murray HW
    Clin Infect Dis; 2007 Sep; 45(5):556-61. PubMed ID: 17682988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of amphoglucamine in experimental candidiasis in sex hormone administration].
    Mikhaĭlova MA; Ezhkov GA
    Antibiotiki; 1981 Jun; 26(6):469-73. PubMed ID: 7271261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
    Sundar S; Mehta H; Suresh AV; Singh SP; Rai M; Murray HW
    Clin Infect Dis; 2004 Feb; 38(3):377-83. PubMed ID: 14727208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B for the treatment of visceral leishmaniasis.
    Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J
    Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis.
    O'Brien CR; Krockenberger MB; Martin P; Wigney DI; Malik R
    Aust Vet J; 2006 Nov; 84(11):384-92. PubMed ID: 17092323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):851-4. PubMed ID: 6735649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.